Zoetis

Active

Overview

Zoetis is the world's largest animal health company, producing medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions for companion animals and livestock. It operates in over 100 countries, with products marketed directly in about 45, generating annual revenue of approximately $9.5 billion as of 2025, split between 70% companion animals and 30% livestock. The company focuses on the continuum of care—predict, prevent, detect, and treat—through data-driven R&D and advanced manufacturing.

History

Zoetis originated as Pfizer's animal health division with nearly 75 years of experience. In 2012, Pfizer announced plans to spin it off, and Zoetis became independent in 2013, joining the S&P 500. Key acquisitions include Pharmaq in 2015, Nexvet and KL Automation in 2017, Abaxis in 2018, Jurox in 2021, and Basepaws in 2022.

Product Lines

Product Line	Positioning	Price Range
Parasiticides (flea, tick, worm control)	Leading protection for companion animals	$10 - $200
Vaccines (disease prevention)	Core immunization for pets and livestock	$20 - $150
Dermatology (skin treatments)	Targeted therapies for animal skin conditions	$30 - $250
Anti-infectives (antibiotics)	Infection control for various species	$15 - $100
Pain & Sedation (anesthesia aids)	Support for veterinary procedures	$25 - $300
Diagnostics (testing tools)	Rapid disease detection platforms	$50 - $500

Manufacturing

Zoetis operates 23 manufacturing sites globally to produce vaccines, medicines, diagnostics, and biodevices. It integrates advanced in-house manufacturing with rigorous science for its portfolio. Products support companion animals and livestock across 100+ countries.

Notable Products

Revolution (selamectin) - Topical parasiticide for flea, tick, heartworm prevention in cats and dogs.
Apoquel (oclacitinib) - Oral treatment for allergic dermatitis in dogs.
Cytopoint - Injectable monoclonal antibody for itch relief in atopic dermatitis.
Librela (bedinvetmab) - Monoclonal antibody for osteoarthritis pain in dogs.
Synovectin CA1 - Intra-articular radiation therapy for equine joint disease.
Excede - Long-acting antibiotic for livestock respiratory disease.

Reputation

Zoetis is regarded by veterinarians and producers as the leading animal health provider due to its extensive portfolio, innovation in biologics and diagnostics, and global reach. Professionals value its blockbuster products like Apoquel and Revolution for efficacy in companion animal care. Some criticisms involve high pricing of branded therapeutics and concerns over antibiotic stewardship in livestock applications.

Sources (6)